SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 116 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.81 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $23,000 | +15.0% | 29,524 | +89.3% | 0.00% | – |
Q4 2021 | $20,000 | -85.7% | 15,597 | -54.5% | 0.00% | -100.0% |
Q3 2020 | $140,000 | -84.6% | 34,252 | -67.6% | 0.00% | -83.3% |
Q2 2019 | $909,000 | +64.4% | 105,556 | +104.1% | 0.01% | +50.0% |
Q1 2019 | $553,000 | -79.6% | 51,714 | -83.3% | 0.00% | -80.0% |
Q4 2018 | $2,708,000 | +162.1% | 309,497 | +519.0% | 0.02% | +300.0% |
Q3 2018 | $1,033,000 | -85.3% | 50,000 | -85.1% | 0.01% | -84.4% |
Q2 2018 | $7,022,000 | +13.8% | 335,028 | -12.6% | 0.03% | +23.1% |
Q1 2018 | $6,169,000 | -42.0% | 383,423 | -31.6% | 0.03% | -21.2% |
Q4 2017 | $10,629,000 | +13885.5% | 560,918 | +4348.9% | 0.03% | +3200.0% |
Q4 2015 | $76,000 | -97.6% | 12,608 | -96.6% | 0.00% | -97.6% |
Q3 2013 | $3,129,000 | +179.6% | 373,336 | +148.9% | 0.04% | +121.1% |
Q2 2013 | $1,119,000 | – | 150,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 7,383,466 | $139,917,000 | 12.64% |
ASHFORD CAPITAL MANAGEMENT INC | 362,615 | $6,872,000 | 1.07% |
NEXTHERA CAPITAL LP | 259,300 | $4,914,000 | 0.91% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 639,856 | $12,125,000 | 0.89% |
Sonora Investment Management, LLC | 249,502 | $4,728,063,000 | 0.76% |
Kazazian Asset Management, LLC | 32,526 | $616,000 | 0.63% |
Piermont Capital Management Inc. | 88,372 | $1,675,000 | 0.55% |
J. Goldman & Co LP | 266,479 | $5,050,000 | 0.26% |
J. Goldman & Co LP | 251,500 | $4,766,000 | 0.25% |
Opaleye Management Inc. | 31,000 | $587,000 | 0.19% |